We continue to develop resources related to the COVID-19 pandemic. See COVID-19 initiatives on Appropedia for more information.

Microlife 3BTO-A

From Appropedia
Jump to navigation Jump to search

This Global Health Medical Device is designed for or implemented within resource-limited settings - Browse the devices - Add a device


Pro bp3bto-ap f.gif
Health Topic Maternal mortality
Classification Diagnosis
Scope Commercialized
Location Africa, Asia, Australia, Europe, North America, South America

Problem being addressed[edit]

Many women in underdeveloped countries suffer from preeclampsia. Preeclampsia is a condition that typically starts after the 20th week of pregnancy and is related to increased blood pressure and protein in the mother's urine (as a result of kidney problems). Preeclampsia affects the placenta, and it can affect the mother's kidney, liver, and brain. When preeclampsia causes seizures, the condition is known as eclampsia--the second leading cause of maternal death in the U.S. Preeclampsia is also a leading cause of fetal complications, which include low birth weight, premature birth, and stillbirth.

Detailed description of the solution[edit]

It is a blood pressure monitor. This device performs pulse arrhythmia detection. It is clinically tested, very easy to use.

Designed by[edit]

  • Designed by: Microlife Corporation Scientists
  • Manufacturer (if different):
  • Manufacturer location:

When and where it was tested/implemented[edit]

Funding Source[edit]

References[edit]

Peer-reviewed publication[edit]

Other internally generated reports[edit]

Externally generated reports[edit]

de Greeff A, Nathan H, Stafford N, Liu B, Shennan AH. Development of an accurate oscillometric blood pressure device for low resource settings. Blood Press Monit 2008;13:342-8.

IP and copyright[edit]

Approval by regulatory bodies or standards boards[edit]

... more about "Microlife 3BTO-A"
Africa +, Asia +, Australia +, Europe +, North America +  and South America +
Commercialized +
Maternal mortality +